Zustand
Asthma
Dieser Zustand hat die folgenden Symptome:
Shortness of BreathWheezingCoughingChest TightnessDifficulty SleepingRapid BreathingFatigueÜberblick
Asthma is a chronic lung condition characterized by difficulty breathing due to inflamed and narrowed airways. Common symptoms include wheezing, coughing, shortness of breath, and chest tightness, which can vary in intensity and may worsen during physical activity or at night. It affects people of all ages but often begins in childhood, with both genetic and environmental factors playing a role in its development. While asthma can be managed effectively with medications such as inhalers and lifestyle adjustments, severe cases can be life-threatening if not properly treated. Mortality rates have decreased with improved treatments, but it remains a significant health concern worldwide.
Kurzübersicht
Symptome
Symptoms include shortness of breath, often felt during physical activity or at night, and wheezing, which is a high-pitched whistling sound noticeable when exhaling. Persistent coughing, particularly at night or early morning, may occur without producing mucus. Individuals may experience chest tightness, described as a sensation of pressure or constriction. Difficulty sleeping due to coughing, wheezing, or shortness of breath can lead to daytime fatigue. Rapid breathing and feeling unusually tired or weak are also common, especially when symptoms worsen.
Ausblick und Prognose
The outlook for individuals with asthma varies, but many can lead normal, active lives with proper management and treatment. Regular use of prescribed medications and avoiding triggers can significantly reduce symptoms and improve quality of life. While asthma is a chronic condition, advancements in treatment have greatly enhanced the ability to control and manage it effectively.
Ursachen und Risikofaktoren
Asthma is influenced by both genetic predispositions and environmental exposures. A family history of asthma significantly increases the likelihood of developing the condition, while environmental triggers such as allergens, tobacco smoke, and air pollution can heighten risk. Other contributing factors include early childhood respiratory infections, frequent exposure to cold air or physical activity, obesity, and stress.
Genetische Einflüsse
Genetics and genetic variations play a significant role in the development and severity of asthma. Certain genes can influence how the immune system responds to environmental triggers, making some individuals more susceptible. Variations in these genes can affect the likelihood of developing asthma and the intensity of symptoms experienced. Understanding these genetic factors can help in identifying at-risk individuals and tailoring more effective treatments.
Diagnose
Asthma is diagnosed through a combination of reviewing the patient's medical history, conducting a physical examination, and performing tests like spirometry and peak flow measurement to evaluate lung function. Additional tests, such as the methacholine challenge and allergy testing, may be used to identify specific triggers or confirm the diagnosis if initial results are inconclusive. The exhaled nitric oxide test can also be employed to assess airway inflammation.
Behandlung und Medikamente
Treatment involves using quick-relief medications like albuterol and levalbuterol to relax airway muscles and provide immediate relief from symptoms. Long-term control is achieved with medications such as inhaled corticosteroids like fluticasone and budesonide, which reduce airway inflammation, and bronchodilators like salmeterol and formoterol, which help maintain open airways. Additional options include leukotriene receptor antagonists like montelukast and zafirlukast, theophylline for long-term control, and omalizumab for severe cases to reduce allergic responses.
Symptome
Asthma symptoms can vary from person to person and may change over time. They often occur in response to triggers such as allergens, exercise, or respiratory infections. Recognizing these symptoms early can help in managing the condition effectively.
Shortness of Breath: A feeling of not being able to get enough air, often occurring during physical activity or at night.
Wheezing: A high-pitched whistling sound made while breathing, particularly noticeable when exhaling.
Coughing: Persistent cough that may worsen at night or early in the morning, often without producing mucus.
Chest Tightness: A sensation of pressure or constriction in the chest, which can be uncomfortable and alarming.
Difficulty Sleeping: Trouble sleeping due to coughing, wheezing, or shortness of breath, leading to fatigue during the day.
Rapid Breathing: An increased breathing rate that can occur during an asthma attack or when symptoms worsen.
Fatigue: Feeling unusually tired or weak, which can result from poor sleep or the effort of breathing.
Wie Menschen es normalerweise zuerst bemerken
Individuals often first notice asthma through symptoms such as frequent coughing, especially at night or during exercise, wheezing or a whistling sound when breathing, and shortness of breath or a feeling of tightness in the chest. These symptoms may vary in intensity and can be triggered by factors like allergens, cold air, or physical activity. Early recognition of these signs is crucial for seeking appropriate medical evaluation and management.
Arten von Asthma
Asthma manifests in various forms, each with distinct symptoms. These variations can be triggered by different factors and may require specific management strategies. Understanding the differences can aid in recognizing and addressing the condition effectively.
Allergic Asthma
Triggered by allergens such as pollen, dust mites, or pet dander. Symptoms include wheezing, coughing, and shortness of breath, often accompanied by itchy eyes or a runny nose. It is commonly associated with other allergic conditions like hay fever.
Non-Allergic Asthma
Not triggered by allergens but by factors such as stress, exercise, or cold air. Symptoms are similar to allergic asthma, including wheezing and coughing, but without the allergic reactions like itchy eyes. It can be more challenging to identify triggers compared to allergic asthma.
Exercise-Induced Asthma
Occurs during or after physical activity. Symptoms include shortness of breath, chest tightness, and coughing, which typically start a few minutes into exercise and may worsen in cold, dry air. It can affect both athletes and non-athletes alike.
Occupational Asthma
Triggered by inhaling fumes, gases, dust, or other potentially harmful substances at work. Symptoms include wheezing, coughing, and chest tightness, often improving when away from the workplace. It can develop over time, even if the individual has not previously had asthma.
Nocturnal Asthma
Symptoms worsen at night, potentially disrupting sleep. Common symptoms include coughing, wheezing, and difficulty breathing, often leading to sleep disturbances. It may be triggered by allergens in the bedroom or changes in body position during sleep.
Cough-Variant Asthma
Characterized primarily by a persistent, dry cough. Unlike other types, wheezing and shortness of breath may not be present. It can be challenging to diagnose as the cough may be mistaken for other respiratory conditions.
Wussten Sie schon?
Certain genetic variations can lead to increased mucus production and airway inflammation, which are symptoms of asthma. These genetic differences can affect how the body responds to environmental triggers, making some individuals more susceptible to asthma symptoms.
Dr. Wallerstorfer
Ursachen und Risikofaktoren
Asthma can be triggered by a combination of genetic and environmental factors. Family history plays a significant role, as individuals with parents or siblings who have asthma are more likely to develop the condition. Environmental factors such as exposure to allergens like pollen, dust mites, and pet dander, as well as irritants like tobacco smoke and air pollution, can increase the risk. Respiratory infections during early childhood and frequent exposure to cold air or exercise can also contribute to the development of asthma. Additionally, obesity and stress have been identified as potential risk factors that may exacerbate symptoms.
Umwelt- und biologische Risikofaktoren
Asthma is influenced by various environmental and biological factors that can trigger or worsen symptoms. Environmental factors include exposure to allergens, air pollution, and occupational hazards. Biological factors involve respiratory infections and hormonal changes. Understanding these factors can help in managing and preventing asthma attacks.
Allergens: Common allergens such as pollen, dust mites, mold, and pet dander can trigger asthma symptoms. These allergens can cause inflammation in the airways, leading to difficulty in breathing. Reducing exposure to these allergens can help manage symptoms.
Air Pollution: Air pollution, including vehicle emissions and industrial pollutants, can exacerbate asthma symptoms. Pollutants can irritate the airways and lead to increased asthma attacks. Monitoring air quality and minimizing exposure can be beneficial.
Occupational Hazards: Certain occupations expose individuals to dust, chemicals, or fumes that can trigger asthma. Jobs in construction, farming, and manufacturing are examples where such exposure is common. Protective measures and proper ventilation can reduce risks.
Respiratory Infections: Viral infections like the common cold or flu can worsen asthma symptoms. These infections can lead to inflammation and narrowing of the airways. Preventive measures such as vaccinations can help reduce the risk.
Hormonal Changes: Hormonal fluctuations, particularly in women, can affect asthma symptoms. Changes during menstruation, pregnancy, or menopause can lead to increased asthma attacks. Monitoring symptoms and adjusting treatment can help manage these changes.
Genetische Risikofaktoren
Asthma has a significant genetic component, with various genes contributing to the risk of developing the condition. These genes are involved in immune system regulation, inflammation, and airway responsiveness. Genetic predisposition can influence how the body reacts to allergens and irritants, potentially leading to asthma symptoms. Understanding these genetic factors can help in identifying individuals at higher risk.
ADAM33: The ADAM33 gene is associated with airway remodeling and inflammation. Variations in this gene can lead to changes in the structure of the airways, making them more susceptible to asthma. It plays a role in the development and progression of asthma symptoms.
ORMDL3: The ORMDL3 gene is linked to the regulation of immune responses. Variants in this gene can increase the likelihood of developing asthma by affecting how the immune system responds to environmental triggers. It is often associated with early-onset asthma.
IL4: The IL4 gene is involved in the production of a protein that influences immune responses. Changes in this gene can lead to an increased production of antibodies that trigger allergic reactions, contributing to asthma. It is a key player in the body's response to allergens.
IL13: The IL13 gene is similar to IL4 in its role in immune response regulation. Variations in this gene can enhance the production of proteins that cause inflammation and allergic reactions. It is often linked to the severity of asthma symptoms.
DPP10: The DPP10 gene is associated with airway hyperresponsiveness. Genetic variations in this gene can lead to increased sensitivity of the airways, which is a hallmark of asthma. It influences how the airways react to various stimuli.
GSDMB: The GSDMB gene is involved in cell death and inflammation processes. Variants in this gene can contribute to the development of asthma by affecting the inflammatory response in the airways. It is often studied in relation to asthma severity and persistence.
HLA-DQ: The HLA-DQ gene is part of the human leukocyte antigen system, which is crucial for immune system function. Variations in this gene can influence the body's ability to distinguish between self and non-self, affecting asthma risk. It is associated with the body's response to allergens.
Dr. Wallerstorfer
Lebensstil-Risikofaktoren
Lifestyle choices can significantly impact the risk of developing or exacerbating asthma. Diet and exercise are two key areas where lifestyle changes can influence asthma symptoms. Maintaining a healthy weight, avoiding certain foods, and engaging in regular physical activity are important considerations. Understanding these factors can help in managing asthma effectively.
Diet: Certain foods and dietary habits can trigger asthma symptoms. High consumption of processed foods, low intake of fruits and vegetables, and food allergies can contribute to asthma risk. A balanced diet rich in antioxidants and omega-3 fatty acids may help reduce inflammation and improve lung function.
Exercise: Regular physical activity is generally beneficial, but intense exercise can sometimes trigger asthma symptoms. It is important to find a balance and choose activities that are less likely to cause breathing difficulties. Warm-up exercises and staying hydrated can help minimize exercise-induced asthma.
Obesity: Excess body weight is linked to increased asthma risk and severity. Fat tissue can produce inflammatory substances that may affect the lungs. Maintaining a healthy weight through diet and exercise can help manage asthma symptoms.
Smoking: Smoking or exposure to tobacco smoke can worsen asthma symptoms and increase the risk of developing asthma. The chemicals in tobacco smoke irritate the airways and can lead to chronic inflammation. Quitting smoking and avoiding secondhand smoke are crucial for asthma management.
Alcohol Consumption: Alcohol can trigger asthma symptoms in some individuals, particularly those with sulfite sensitivity. Beverages like wine and beer often contain sulfites, which can cause respiratory issues. Moderation and awareness of alcohol content can help manage asthma symptoms.
Risikoprävention
Preventing asthma or reducing the risk of developing it involves minimizing exposure to known triggers and maintaining a healthy lifestyle. Environmental factors, allergens, and lifestyle choices play a significant role in the onset of asthma symptoms. By addressing these factors, individuals can lower their chances of experiencing asthma-related issues.
Avoid Tobacco Smoke: Exposure to tobacco smoke, including secondhand smoke, can increase the risk of developing asthma. Avoiding smoking and staying away from areas where smoking occurs can help reduce this risk.
Reduce Exposure to Allergens: Common allergens such as dust mites, pet dander, and pollen can trigger asthma symptoms. Using air purifiers, keeping living spaces clean, and minimizing contact with pets can help manage exposure to these allergens.
Maintain a Healthy Weight: Being overweight can increase the risk of asthma and worsen its symptoms. Regular physical activity and a balanced diet can help maintain a healthy weight and reduce asthma risk.
Manage Stress: Stress can exacerbate asthma symptoms and trigger attacks. Practicing stress-reducing techniques such as meditation, yoga, or deep-breathing exercises can be beneficial.
Limit Exposure to Air Pollution: Air pollution can irritate the airways and trigger asthma symptoms. Staying indoors on high pollution days and using air filters can help minimize exposure.
Get Vaccinated: Respiratory infections can worsen asthma symptoms. Vaccinations, such as the flu shot, can help prevent infections that may trigger asthma.
Avoid Occupational Triggers: Certain occupations expose individuals to chemicals or dust that can trigger asthma. Using protective equipment and following safety guidelines can reduce exposure to these triggers.
Wie effektiv ist Prävention
Prevention strategies for asthma focus on reducing exposure to known triggers and maintaining a healthy lifestyle. Avoiding tobacco smoke, managing stress, and limiting exposure to allergens and air pollution are effective measures. Maintaining a healthy weight and getting vaccinated against respiratory infections can also help reduce the risk. By addressing these factors, individuals can significantly lower their chances of experiencing asthma symptoms.
Übertragung
Asthma is not an infectious disease and cannot be transferred from one person to another through direct contact, like a cold or flu. It is a chronic condition that often runs in families, suggesting a genetic component. Environmental factors, such as exposure to allergens or pollutants, can also play a role in its development. While asthma itself is not contagious, respiratory infections can trigger asthma symptoms in those who have the condition. Managing environmental triggers and understanding family history are important in addressing asthma.
Wann man seine Gene testen sollte
Genetic testing for early detection or personalized care is advisable if there is a family history of genetic disorders, unexplained symptoms, or when planning for children. It can also be beneficial for individuals with a known risk of hereditary conditions. Consulting with a healthcare professional can guide appropriate testing decisions.
Dr. Wallerstorfer
Diagnose
Asthma diagnosis involves a combination of medical history, physical examination, and specific tests to assess lung function and identify triggers. Doctors often begin by asking about symptoms, family history, and any known allergies. Physical exams help to check for signs of asthma or other conditions that could cause similar symptoms. Various tests are used to measure how well the lungs are working and to confirm the diagnosis.
Medical History: Doctors inquire about the patient's symptoms, frequency, and severity, as well as any family history of asthma or allergies. This information helps to identify patterns and potential triggers.
Physical Examination: A doctor listens to the patient's breathing and checks for signs of asthma, such as wheezing or a persistent cough. This examination helps to rule out other conditions that might cause similar symptoms.
Spirometry: This test measures how much air a person can exhale and how quickly. It helps to assess lung function and determine the presence of airflow obstruction.
Peak Flow Measurement: A peak flow meter is a simple device that measures the rate at which a person can blow air out of their lungs. Regular monitoring can help track asthma control over time.
Methacholine Challenge Test: Methacholine is a substance that, when inhaled, can cause airway narrowing in people with asthma. This test is used if initial spirometry results are normal but asthma is still suspected.
Allergy Testing: Skin or blood tests can identify specific allergens that may trigger asthma symptoms. Identifying these allergens can help in managing and avoiding triggers.
Exhaled Nitric Oxide Test: This test measures the level of nitric oxide in the breath, which can be higher in people with asthma. It helps to assess inflammation in the airways.
Stadien von Asthma
Asthma progresses through various stages, each characterized by the frequency and severity of symptoms. These stages help in determining the appropriate treatment and management strategies. Understanding these stages is crucial for effective control and prevention of exacerbations.
Intermittent Asthma
Symptoms occur less than twice a week, and nighttime symptoms happen less than twice a month. There are no symptoms between flare-ups, and lung function is normal when not experiencing an attack.
Mild Persistent Asthma
Symptoms appear more than twice a week but not daily, and nighttime symptoms occur three to four times a month. Lung function tests are usually normal, but flare-ups might affect daily activities.
Moderate Persistent Asthma
Symptoms occur daily, and nighttime symptoms happen more than once a week. Lung function is reduced, and flare-ups can significantly interfere with daily life.
Severe Persistent Asthma
Symptoms are continuous, and nighttime symptoms are frequent. Lung function is severely reduced, and daily activities are extremely limited due to frequent flare-ups.
Wussten Sie über genetische Tests?
Genetic testing can identify specific genes that increase the risk of developing asthma, allowing for early interventions and personalized treatment plans. By understanding an individual's genetic predisposition, healthcare providers can recommend lifestyle changes or medications that are more likely to be effective. This tailored approach can help in managing symptoms more efficiently and potentially reducing the severity of asthma attacks.
Dr. Wallerstorfer
Ausblick und Prognose
The outlook for individuals with asthma varies widely depending on several factors, including the severity of the condition, access to medical care, and adherence to treatment plans. Many people with asthma can lead normal, active lives with proper management, which typically involves avoiding triggers, using prescribed medications, and monitoring symptoms. Advances in treatment, such as inhaled corticosteroids and bronchodilators, have significantly improved the quality of life for those affected.
The prognosis is generally favorable for those who manage their condition effectively. However, asthma can be more challenging for some, particularly if it is severe or poorly controlled. In such cases, individuals may experience frequent symptoms and exacerbations, which can impact daily activities and overall well-being. Regular follow-ups with healthcare providers are crucial to adjust treatment plans as needed and to ensure optimal control of the condition.
Mortality rates associated with asthma have decreased over the years due to better treatment options and increased awareness. Nonetheless, asthma can still be life-threatening, particularly during severe attacks. It is essential for individuals with asthma to recognize the signs of worsening symptoms and to seek medical attention promptly when necessary. Education on the proper use of medications and the importance of adherence to treatment regimens plays a critical role in reducing the risk of severe outcomes.
Langzeitwirkungen
Asthma can lead to several long-term effects on an individual's health and quality of life. These effects can vary in severity and may impact different aspects of daily living. Understanding these potential outcomes is crucial for managing the condition effectively.
Chronic Inflammation: Persistent inflammation in the airways can lead to long-term damage and scarring, making breathing more difficult over time. This can result in a permanent narrowing of the airways, reducing lung function.
Frequent Respiratory Infections: Individuals with asthma may experience more frequent respiratory infections, such as colds and flu. This is due to the weakened state of the airways, which are more susceptible to infections.
Decreased Lung Function: Over time, asthma can lead to a gradual decline in lung function, making it harder to breathe. This can limit physical activities and reduce overall stamina.
Psychological Effects: Living with a chronic condition like asthma can lead to stress, anxiety, and depression. The fear of asthma attacks and the need for constant management can impact mental health.
Impact on Daily Life: Asthma can affect daily activities, including work, school, and exercise. The need for ongoing medication and the possibility of sudden attacks can disrupt normal routines.
Sleep Disturbances: Asthma symptoms often worsen at night, leading to sleep disturbances. Poor sleep quality can affect overall health and well-being.
Wie ist es, mit Asthma zu leben
Living with asthma involves managing symptoms that can include difficulty breathing, coughing, and wheezing, which may be triggered by various environmental factors. Daily life can be affected by the need to avoid certain activities or places that might provoke symptoms, and individuals often carry inhalers for quick relief. The condition can also impact those around the individual, as family and friends may need to be aware of triggers and assist in managing sudden symptoms. Social activities might require adjustments to ensure a safe environment, fostering a supportive network for the individual.
Behandlung und Medikamente
Asthma treatment involves using medications to manage symptoms and prevent attacks. Quick-relief medications, such as bronchodilators, are used to relax airway muscles and provide immediate relief. Long-term control medications, including inhaled corticosteroids and leukotriene receptor antagonists, help reduce airway inflammation and prevent symptoms over time. In severe cases, monoclonal antibodies may be prescribed to target allergic responses. The choice of treatment is tailored to the individual's symptom severity and frequency.
Nicht-medikamentöse Behandlung
Non-pharmacological treatments for asthma focus on lifestyle changes and therapies that help manage symptoms and improve quality of life. These treatments can be used alongside medications to provide a comprehensive approach to asthma management. They often involve environmental control, physical activities, and breathing techniques. Such interventions aim to reduce triggers and enhance lung function.
Breathing Exercises: Breathing exercises, such as the Buteyko method or diaphragmatic breathing, help improve lung function and reduce asthma symptoms. These techniques focus on controlling breathing patterns to increase airflow and decrease breathlessness. Regular practice can lead to better management of asthma symptoms.
Physical Activity: Engaging in regular physical activity can strengthen respiratory muscles and improve overall lung capacity. Activities like swimming, walking, or cycling are often recommended as they are less likely to trigger asthma symptoms. Exercise should be tailored to individual capabilities and done in a controlled environment.
Environmental Control: Reducing exposure to asthma triggers such as dust mites, pet dander, and pollen can significantly improve symptoms. This may involve using air purifiers, maintaining cleanliness, and avoiding smoking areas. Creating an asthma-friendly environment helps in minimizing attacks.
Dietary Changes: A balanced diet rich in fruits, vegetables, and omega-3 fatty acids can support overall health and potentially reduce inflammation. Some studies suggest that certain foods may help in managing asthma symptoms. Avoiding known food allergens is also crucial for individuals with food-related asthma triggers.
Stress Management: Stress management techniques such as yoga, meditation, and mindfulness can help in reducing asthma symptoms. Stress is known to exacerbate asthma, so learning to manage it can lead to fewer attacks. These practices promote relaxation and better breathing control.
Acupuncture: Acupuncture is used by some individuals as a complementary therapy to help manage asthma symptoms. It involves inserting thin needles into specific points on the body to promote healing and reduce symptoms. While evidence is mixed, some people report improvements in their condition.
Wussten Sie, dass Medikamente von Genen beeinflusst werden?
Genetic differences can affect how individuals respond to asthma medications, influencing both effectiveness and potential side effects. Personalized treatment plans based on genetic information may improve outcomes by tailoring medication choices to each person's unique genetic makeup.
Dr. Wallerstorfer
Pharmakologische Behandlungen
Asthma is managed using a variety of medications that help control symptoms and prevent attacks. These medications can be categorized into quick-relief and long-term control medications. Quick-relief medications provide immediate relief from acute symptoms, while long-term control medications help reduce inflammation and prevent future episodes. The choice of medication depends on the severity and frequency of symptoms.
Albuterol: A quick-relief bronchodilator that relaxes muscles in the airways and increases airflow to the lungs.
Levalbuterol: Similar to albuterol, it is used for quick relief of asthma symptoms by relaxing airway muscles.
Salmeterol: A long-acting bronchodilator used for maintenance treatment to prevent asthma symptoms.
Formoterol: Another long-acting bronchodilator that helps in controlling asthma symptoms over time.
Fluticasone: An inhaled corticosteroid that reduces inflammation in the airways, used for long-term control.
Budesonide: An inhaled corticosteroid that helps decrease inflammation and prevent asthma attacks.
Montelukast: A leukotriene receptor antagonist that helps prevent asthma symptoms by blocking substances that cause inflammation.
Zafirlukast: Similar to montelukast, it is used to prevent asthma symptoms by blocking inflammatory substances.
Theophylline: A bronchodilator that helps open airways and is used for long-term control of asthma symptoms.
Omalizumab: A monoclonal antibody used for severe asthma cases, targeting and reducing allergic responses.
Genetische Einflüsse
Genetics play a significant role in the development of asthma, with research indicating that the condition often runs in families. Specific genes have been identified that increase the likelihood of developing asthma, particularly those involved in the immune system and inflammatory responses. These genetic factors can influence how the body reacts to environmental triggers, such as allergens or pollutants, which can exacerbate symptoms. While having a family history of asthma can increase risk, it is not the sole determinant, as environmental factors also contribute to the condition's onset and severity. Studies have shown that interactions between multiple genes and environmental influences are complex, making it challenging to predict asthma solely based on genetic information. Understanding the genetic basis of asthma can help in developing personalized treatment strategies and preventive measures.
Genvariationen
Genetic variations can significantly influence the likelihood of developing asthma and its severity. These variations can affect immune system function, airway inflammation, and response to environmental triggers. Understanding these genetic factors can help in identifying individuals at higher risk and tailoring personalized treatment strategies.
IL4 Gene: Variations in the IL4 gene can lead to increased production of a protein that promotes inflammation in the airways. This can result in a higher risk of developing asthma and more severe symptoms.
ADAM33 Gene: The ADAM33 gene is associated with airway remodeling, which can contribute to the chronic nature of asthma. Variations in this gene may lead to changes in the structure of the airways, making them more susceptible to inflammation.
ORMDL3 Gene: Variations in the ORMDL3 gene have been linked to increased susceptibility to asthma. This gene is involved in the regulation of immune responses and inflammation, which are key factors in asthma development.
IL13 Gene: The IL13 gene is involved in the immune response and has been associated with increased asthma risk. Variations in this gene can lead to higher levels of inflammation in the airways.
Filaggrin (FLG) Gene: Mutations in the Filaggrin gene can lead to a compromised skin barrier, which is associated with an increased risk of asthma. This gene plays a role in maintaining the integrity of the skin and mucosal barriers, which can affect the body's response to allergens.
TSLP Gene: The TSLP gene is involved in the immune system's response to allergens. Variations in this gene can increase the risk of developing asthma by promoting inflammation and allergic reactions.
Variant Table Legend
Clinical Testing
Scientific Studies
Biological Male Symbol
Biological Female Symbol
Unisex Symbol for both Genders
Varianten, die Asthma basierend auf klinischen Tests beeinflussen
Klinische Testklassifikationen sind darauf ausgelegt, Ärzten dabei zu helfen, zu verstehen, wie genetische Veränderungen, bekannt als Varianten, die Gesundheit einer Person beeinflussen könnten und medizinische Entscheidungen leiten. Varianten werden als Krankheitsverursachend (schädlich), Wahrscheinlich Krankheitsverursachend, Unbekannte Wirkung (unbekannte Auswirkung), Wahrscheinlich Keine Wirkung (wahrscheinlich nicht schädlich) und Keine Wirkung (nicht schädlich) gekennzeichnet. Diese Klassifizierung stützt sich auf eine Mischung aus Familiengeschichte, Labortests und Computerprognosen, um die Auswirkungen der Varianten zu bestimmen.
Varianten, die sowohl biologische Männer als auch Frauen betreffen
34377097
Genotype
A
A
Level of evidence
Unbekannter Effekt
Unisex
1 Sources
Participants: 0
The genotype with the letters A/A has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Genotype
C
C
Level of evidence
Kein Effekt
Unisex
1 Sources
Participants: 0
The genotype with the letters C/C is thought to have no effect on your disease risk. Carriers of this genetic result are usually not at risk of developing the disease.
Genotype
A
C
Level of evidence
Unbekannter Effekt
Unisex
1 Sources
Participants: 0
The genotype with the letters A/C has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Genotype
A
A
Level of evidence
Unbekannter Effekt
Unisex
1 Sources
Participants: 0
The genotype with the letters A/A has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Genotype
C
C
Level of evidence
Kein Effekt
Unisex
1 Sources
Participants: 0
The genotype with the letters C/C is thought to have no effect on your disease risk. Carriers of this genetic result are usually not at risk of developing the disease.
Genotype
A
C
Level of evidence
Unbekannter Effekt
Unisex
1 Sources
Participants: 0
The genotype with the letters A/C has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Varianten, die Asthma basierend auf wissenschaftlichen Studien beeinflussen
Wissenschaftliche Studienklassifikationen zielen darauf ab, herauszufinden, wie genetische Varianten funktionieren und welche Rolle sie bei Krankheiten, Merkmalen und der Evolution spielen. Varianten werden basierend auf ihrer funktionellen Auswirkung kategorisiert, wie etwa Funktionsverlust (verringert die Genaktivität), Funktionsgewinn (erhöht die Genaktivität), neutral (keine signifikante Auswirkung) oder evolutionäre Konservierung. Diese Klassifizierung nutzt experimentelle Daten, Populationsstudien und computerbasierte Analysen, um die Auswirkungen von Varianten zu verstehen. Im Gegensatz zu klinischen Tests, die sich auf unmittelbare gesundheitliche Auswirkungen konzentrieren, erforschen wissenschaftliche Studien breitere genetische Mechanismen und langfristige Implikationen.
Varianten, die sowohl biologische Männer als auch Frauen betreffen
992969
Genotype
A
A
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/A is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
G
Level of evidence
Kein Effekt
Unisex
0 Sources
Participants: 0
No available data
Genotype
A
C
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/C is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
T
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
A
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/A is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
G
Level of evidence
Kein Effekt
Unisex
0 Sources
Participants: 0
No available data
Genotype
A
C
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/C is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
T
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
6 Sources
Participants: 2280901
The genotype with the letters A/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
7626218
Genotype
A
A
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/A is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
T
T
Level of evidence
Kein Effekt
Unisex
0 Sources
Participants: 0
No available data
Genotype
A
C
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/C is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
T
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
A
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/A is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
T
T
Level of evidence
Kein Effekt
Unisex
0 Sources
Participants: 0
No available data
Genotype
A
C
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/C is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
T
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
4 Sources
Participants: 1810745
The genotype with the letters A/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters G/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
C
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters C/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
T
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters G/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters A/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters G/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
C
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters C/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
T
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters G/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
A
G
Level of evidence
Erhöhte Wahrscheinlichkeit
Unisex
3 Sources
Participants: 345240
The genotype with the letters A/G is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Varianten, die Asthma beeinflussen
Alle Varianten, die das Risiko für die Entwicklung von Asthma beeinflussen, sind hier aufgelistet.
Gene, die Asthma beeinflussen
Alle Gene die Varianten enthalten, welche das Risiko für die Entwicklung von Asthma beeinflussen, sind hier aufgelistet.
Pharmakogenetik - wie Genetik Medikamente beeinflusst
Genetics play a significant role in determining how individuals respond to asthma treatments. Variations in certain genes can influence how well a person responds to common asthma medications, such as inhaled corticosteroids and bronchodilators. For example, some people have genetic differences that make them more or less responsive to these drugs, affecting their effectiveness in controlling symptoms. Pharmacogenomics, the study of how genes affect a person's response to drugs, is helping to tailor asthma treatments to individual genetic profiles, potentially leading to more effective and personalized care. Researchers are also exploring how genetic markers can predict the risk of side effects from asthma medications, allowing for safer treatment plans. Understanding these genetic influences can improve treatment outcomes and enhance the quality of life for those affected.
Von Genetik beeinflusste Medikamente
Dr. Wallerstorfer
Wechselwirkungen mit anderen Krankheiten
Asthma can interact with several other diseases, influencing both its management and the overall health of individuals. One notable interaction is with allergic rhinitis, where inflammation in the nasal passages can exacerbate asthma symptoms. Additionally, asthma often coexists with chronic obstructive pulmonary disease (COPD), a condition that affects breathing, and this overlap can complicate treatment strategies. Gastroesophageal reflux disease (GERD) is another condition that can worsen asthma symptoms, as stomach acid can irritate the airways. Furthermore, respiratory infections, such as the common cold or flu, can trigger asthma attacks, making it crucial for individuals to manage these infections promptly. Understanding these interactions is essential for effective management and treatment of asthma.
Besondere Lebensumstände
Asthma can manifest differently across various life stages and conditions. During pregnancy, hormonal changes can either worsen or improve symptoms, and careful management is crucial to ensure the health of both the mother and the developing baby. In older adults, asthma may be complicated by other age-related health issues, and symptoms might be mistaken for other respiratory conditions, necessitating precise diagnosis and treatment. Children with asthma often experience symptoms triggered by common colds or physical activity, and managing their condition involves a balance of medication and lifestyle adjustments. Active athletes with asthma may face challenges during intense physical exertion, but with proper management and preventive measures, they can often continue to perform at high levels. Each of these groups requires tailored approaches to effectively manage their symptoms and maintain quality of life.
Geschichte
Asthma has a long and storied history, with its roots tracing back to ancient civilizations. The earliest known references to asthma-like symptoms appear in ancient Egyptian texts dating back to around 1550 BCE. These texts describe respiratory distress and suggest treatments involving inhalation of certain herbs. The term "asthma" itself is derived from the Greek word "ásthma," meaning "panting" or "short-drawn breath," and was first used by the Greek physician Hippocrates around 400 BCE. Hippocrates recognized asthma as a distinct condition, noting its episodic nature and potential triggers.
Throughout history, asthma has been a significant health concern, affecting individuals across various cultures and societies. During the Middle Ages, asthma was often attributed to supernatural causes or imbalances in bodily humors, a theory prevalent in medieval medicine. Treatments during this period were largely ineffective, relying on herbal remedies and mystical practices.
The understanding of asthma began to evolve significantly during the 19th century with advancements in medical science. Physicians started to recognize the role of the airways in asthma and began to explore the underlying mechanisms of the condition. The industrial revolution brought about increased pollution and urbanization, leading to a rise in respiratory illnesses, including asthma. This period saw the first major outbreaks of asthma, particularly in rapidly growing cities.
The development of effective treatments for asthma gained momentum in the 20th century. In the early 1900s, adrenaline was discovered to provide relief from asthma symptoms by relaxing the muscles around the airways. This breakthrough paved the way for the development of bronchodilators, medications that help open the airways and ease breathing. The mid-20th century saw the introduction of corticosteroids, which help reduce inflammation in the airways, providing long-term control of asthma symptoms.
The impact of asthma on mankind has been profound, affecting millions of people worldwide. It can significantly impact quality of life, leading to missed school and workdays, and in severe cases, hospitalization. Despite advancements in treatment, asthma remains a major public health challenge, particularly in low-income and developing regions where access to healthcare is limited.
Current research in asthma is focused on understanding the genetic and environmental factors that contribute to the condition. Scientists are exploring the role of the immune system and the microbiome in asthma development, aiming to identify new therapeutic targets. Advances in personalized medicine are also being pursued, with the goal of tailoring treatments to individual patients based on their specific genetic and environmental profiles.
Innovations in technology are playing a crucial role in asthma research and management. Digital health tools, such as mobile apps and wearable devices, are being developed to help monitor asthma symptoms and improve adherence to treatment plans. These tools have the potential to empower individuals with asthma to take a more active role in managing their condition.
As research continues to advance, there is hope for more effective treatments and, ultimately, a cure for asthma. The ongoing efforts of scientists and healthcare professionals worldwide are aimed at reducing the burden of asthma and improving the lives of those affected by this chronic condition.